Csányi E - Search Results

1

Novel In Vitro Investigational Methods for Modeling Skin Permeation: Skin PAMPA, Raman Mapping.

Zsikó S, Csányi E, Kovács A, Budai-Szűcs M, Gácsi A, Berkó S. Zsikó S, et al. Among authors: csanyi e. Pharmaceutics. 2020 Aug 25;12(9):803. doi: 10.3390/pharmaceutics12090803. Pharmaceutics. 2020. PMID: 32854296 Free PMC article.

2

In vitro and in vivo percutaneous absorption of topical dosage forms: case studies.

Csóka I, Csányi E, Zapantis G, Nagy E, Fehér-Kiss A, Horváth G, Blazsó G, Eros I. Csóka I, et al. Among authors: csanyi e. Int J Pharm. 2005 Mar 3;291(1-2):11-9. doi: 10.1016/j.ijpharm.2004.07.038. Epub 2004 Dec 30. Int J Pharm. 2005. PMID: 15707727

3

Lyotropic liquid crystal preconcentrates for the treatment of periodontal disease.

Fehér A, Urbán E, Eros I, Szabó-Révész P, Csányi E. Fehér A, et al. Among authors: csanyi e. Int J Pharm. 2008 Jun 24;358(1-2):23-6. doi: 10.1016/j.ijpharm.2008.02.025. Epub 2008 Feb 29. Int J Pharm. 2008. PMID: 18403142

4

Ibuprofen penetration enhance by sucrose ester examined by ATR-FTIR in vivo.

Csizmazia E, Eros G, Berkesi O, Berkó S, Szabó-Révész P, Csányi E. Csizmazia E, et al. Among authors: csanyi e. Pharm Dev Technol. 2012 Jan-Feb;17(1):125-8. doi: 10.3109/10837450.2010.508076. Epub 2010 Aug 17. Pharm Dev Technol. 2012. PMID: 20715904

5

A novel murine model for the in vivo study of transdermal drug penetration.

Eros G, Hartmann P, Berkó S, Csizmazia E, Csányi E, Sztojkov-Ivanov A, Németh I, Szabó-Révész P, Zupkó I, Kemény L. Eros G, et al. Among authors: csanyi e. ScientificWorldJournal. 2012;2012:543536. doi: 10.1100/2012/543536. Epub 2012 Jan 4. ScientificWorldJournal. 2012. PMID: 22272176 Free PMC article.

6

[Modelling of pecutaneous drug permeation and investigation of penetration enhancer effect].

Csizmazia E, Berkó S, Maroda M, Szabóné RP, Csányi E. Csizmazia E, et al. Among authors: csanyi e. Acta Pharm Hung. 2012;82(1):15-22. Acta Pharm Hung. 2012. PMID: 22570983 Review. Hungarian.

7

Thiolated poly(aspartic acid) as potential in situ gelling, ocular mucoadhesive drug delivery system.

Horvát G, Gyarmati B, Berkó S, Szabó-Révész P, Szilágyi BÁ, Szilágyi A, Soós J, Sandri G, Bonferoni MC, Rossi S, Ferrari F, Caramella C, Csányi E, Budai-Szűcs M. Horvát G, et al. Among authors: csanyi e. Eur J Pharm Sci. 2015 Jan 25;67:1-11. doi: 10.1016/j.ejps.2014.10.013. Epub 2014 Nov 4. Eur J Pharm Sci. 2015. PMID: 25445832

8

Development of thermosensitive chitosan/glicerophospate injectable in situ gelling solutions for potential application in intraoperative fluorescence imaging and local therapy of hepatocellular carcinoma: a preliminary study.

Salis A, Rassu G, Budai-Szűcs M, Benzoni I, Csányi E, Berkó S, Maestri M, Dionigi P, Porcu EP, Gavini E, Giunchedi P. Salis A, et al. Among authors: csanyi e. Expert Opin Drug Deliv. 2015;12(10):1583-96. doi: 10.1517/17425247.2015.1042452. Epub 2015 May 2. Expert Opin Drug Deliv. 2015. PMID: 25937030

9

Permeability test for transdermal and local therapeutic patches using Skin PAMPA method.

Vizserálek G, Berkó S, Tóth G, Balogh R, Budai-Szűcs M, Csányi E, Sinkó B, Takács-Novák K. Vizserálek G, et al. Among authors: csanyi e. Eur J Pharm Sci. 2015 Aug 30;76:165-72. doi: 10.1016/j.ejps.2015.05.004. Epub 2015 May 7. Eur J Pharm Sci. 2015. PMID: 25957747

10

Study of sodium hyaluronate-based intranasal formulations containing micro- or nanosized meloxicam particles.

Bartos C, Ambrus R, Sipos P, Budai-Szűcs M, Csányi E, Gáspár R, Márki Á, Seres AB, Sztojkov-Ivanov A, Horváth T, Szabó-Révész P. Bartos C, et al. Among authors: csanyi e. Int J Pharm. 2015 Aug 1;491(1-2):198-207. doi: 10.1016/j.ijpharm.2015.06.046. Epub 2015 Jun 30. Int J Pharm. 2015. PMID: 26142244

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

103 results

Search Page